Our results provide the first evidence that, in aggressive EC cells, miR-101 governs multiple malignant phenotypes including proliferation, migration, invasion and cancer stemness, at least partly via downregulating the expression of EZH2, MCL-1 and FOS (Figure 6). The gene discussed is EZH2; the disease is cancer.